Special items: Ovarian Cancer and Us blog best viewed in Firefox

Thursday, April 09, 2015

U.S. FDA Grants Breakthrough Therapy Designation to Rucaparib in Advanced Ovarian Cancer With BRCA Mutations

The ASCO Post

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.